Antihelmintics are a class of drugs used to treat parasitic infections caused by worms, including nematodes, tapeworms, flukes, etc. These drugs work by various mechanisms to kill or expel the parasites, helping to clear worm infections from the body. Helminths are parasites that can live in humans or animals and can cause a variety of diseases that affect the digestive system, respiratory system, blood system, etc.

The global Anti-helminthic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Anti-helminthic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Anti-helminthic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Anti-helminthic Drugs include GlaxoSmithKline, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Fredun Pharmaceuticals Ltd, Salius Pharma, Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-helminthic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-helminthic Drugs.

The Anti-helminthic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-helminthic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-helminthic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-helminthic Drugs Market Report

Report Metric	Details
Report Name	Anti-helminthic Drugs Market
Segment by Type	Praziquantel Albendazole Mimbendazole Piperazine Pyrantel Pamoate
Segment by Application	For Veterinary Use For Human Use
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Fredun Pharmaceuticals Ltd, Salius Pharma, Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Merck, Shanghai Tengrui Pharmaceutical Co., Ltd., Shaanxi Hanwang Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Jiaozuo Furuitang Pharmaceutical Co., Ltd., Shaoxing Minsheng Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Anhui Shengying Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., Zhejiang Anbet Pharmaceutical Co., Ltd., Nanjing Pharmaceutical Factory Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-helminthic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-helminthic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-helminthic Drugs Market report?

Ans: The main players in the Anti-helminthic Drugs Market are GlaxoSmithKline, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Fredun Pharmaceuticals Ltd, Salius Pharma, Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals, Merck, Shanghai Tengrui Pharmaceutical Co., Ltd., Shaanxi Hanwang Pharmaceutical Co., Ltd., Beijing Taiyang Pharmaceutical Co., Ltd., Guilin Nanyao Pharmaceutical Co., Ltd., Fujian Dongrui Pharmaceutical Co., Ltd., Jiaozuo Furuitang Pharmaceutical Co., Ltd., Shaoxing Minsheng Pharmaceutical Co., Ltd., Chengdu Hengda Pharmaceutical Co., Ltd., China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd., Diao Group Chengdu Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Anhui Shengying Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Hubei Ruihua Pharmaceutical Co., Ltd., Zhejiang Anbet Pharmaceutical Co., Ltd., Nanjing Pharmaceutical Factory Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Anti-helminthic Drugs Market report?

Ans: The Applications covered in the Anti-helminthic Drugs Market report are For Veterinary Use, For Human Use

What are the Type segmentation covered in the Anti-helminthic Drugs Market report?

Ans: The Types covered in the Anti-helminthic Drugs Market report are Praziquantel, Albendazole, Mimbendazole, Piperazine, Pyrantel Pamoate

1 Anti-helminthic Drugs Market Overview

1.1 Product Definition

1.2 Anti-helminthic Drugs by Type

1.2.1 Global Anti-helminthic Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Praziquantel

1.2.3 Albendazole

1.2.4 Mimbendazole

1.2.5 Piperazine

1.2.6 Pyrantel Pamoate

1.3 Anti-helminthic Drugs by Application

1.3.1 Global Anti-helminthic Drugs Market Value by Application (2024-2030)

1.3.2 For Veterinary Use

1.3.3 For Human Use

1.4 Global Anti-helminthic Drugs Market Size Estimates and Forecasts

1.4.1 Global Anti-helminthic Drugs Revenue 2019-2030

1.4.2 Global Anti-helminthic Drugs Sales 2019-2030

1.4.3 Global Anti-helminthic Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Anti-helminthic Drugs Market Competition by Manufacturers

2.1 Global Anti-helminthic Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Anti-helminthic Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Anti-helminthic Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Anti-helminthic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Anti-helminthic Drugs, Product Type & Application

2.7 Global Key Manufacturers of Anti-helminthic Drugs, Date of Enter into This Industry

2.8 Global Anti-helminthic Drugs Market Competitive Situation and Trends

2.8.1 Global Anti-helminthic Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Anti-helminthic Drugs Players Market Share by Revenue

2.8.3 Global Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Anti-helminthic Drugs Market Scenario by Region

3.1 Global Anti-helminthic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Anti-helminthic Drugs Sales by Region: 2019-2030

3.2.1 Global Anti-helminthic Drugs Sales by Region: 2019-2024

3.2.2 Global Anti-helminthic Drugs Sales by Region: 2025-2030

3.3 Global Anti-helminthic Drugs Revenue by Region: 2019-2030

3.3.1 Global Anti-helminthic Drugs Revenue by Region: 2019-2024

3.3.2 Global Anti-helminthic Drugs Revenue by Region: 2025-2030

3.4 North America Anti-helminthic Drugs Market Facts & Figures by Country

3.4.1 North America Anti-helminthic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Anti-helminthic Drugs Sales by Country (2019-2030)

3.4.3 North America Anti-helminthic Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Anti-helminthic Drugs Market Facts & Figures by Country

3.5.1 Europe Anti-helminthic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Anti-helminthic Drugs Sales by Country (2019-2030)

3.5.3 Europe Anti-helminthic Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Anti-helminthic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Anti-helminthic Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Anti-helminthic Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Anti-helminthic Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Anti-helminthic Drugs Market Facts & Figures by Country

3.7.1 Latin America Anti-helminthic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Anti-helminthic Drugs Sales by Country (2019-2030)

3.7.3 Latin America Anti-helminthic Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Anti-helminthic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Anti-helminthic Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Anti-helminthic Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Anti-helminthic Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Anti-helminthic Drugs Sales by Type (2019-2030)

4.1.1 Global Anti-helminthic Drugs Sales by Type (2019-2024)

4.1.2 Global Anti-helminthic Drugs Sales by Type (2025-2030)

4.1.3 Global Anti-helminthic Drugs Sales Market Share by Type (2019-2030)

4.2 Global Anti-helminthic Drugs Revenue by Type (2019-2030)

4.2.1 Global Anti-helminthic Drugs Revenue by Type (2019-2024)

4.2.2 Global Anti-helminthic Drugs Revenue by Type (2025-2030)

4.2.3 Global Anti-helminthic Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Anti-helminthic Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Anti-helminthic Drugs Sales by Application (2019-2030)

5.1.1 Global Anti-helminthic Drugs Sales by Application (2019-2024)

5.1.2 Global Anti-helminthic Drugs Sales by Application (2025-2030)

5.1.3 Global Anti-helminthic Drugs Sales Market Share by Application (2019-2030)

5.2 Global Anti-helminthic Drugs Revenue by Application (2019-2030)

5.2.1 Global Anti-helminthic Drugs Revenue by Application (2019-2024)

5.2.2 Global Anti-helminthic Drugs Revenue by Application (2025-2030)

5.2.3 Global Anti-helminthic Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Anti-helminthic Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Company Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GlaxoSmithKline Anti-helminthic Drugs Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Sequent Scientific

6.2.1 Sequent Scientific Company Information

6.2.2 Sequent Scientific Description and Business Overview

6.2.3 Sequent Scientific Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sequent Scientific Anti-helminthic Drugs Product Portfolio

6.2.5 Sequent Scientific Recent Developments/Updates

6.3 K.A. Malle Pharmaceuticals

6.3.1 K.A. Malle Pharmaceuticals Company Information

6.3.2 K.A. Malle Pharmaceuticals Description and Business Overview

6.3.3 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Portfolio

6.3.5 K.A. Malle Pharmaceuticals Recent Developments/Updates

6.4 Lasa Supergenerics Limited

6.4.1 Lasa Supergenerics Limited Company Information

6.4.2 Lasa Supergenerics Limited Description and Business Overview

6.4.3 Lasa Supergenerics Limited Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lasa Supergenerics Limited Anti-helminthic Drugs Product Portfolio

6.4.5 Lasa Supergenerics Limited Recent Developments/Updates

6.5 Fredun Pharmaceuticals Ltd

6.5.1 Fredun Pharmaceuticals Ltd Company Information

6.5.2 Fredun Pharmaceuticals Ltd Description and Business Overview

6.5.3 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Portfolio

6.5.5 Fredun Pharmaceuticals Ltd Recent Developments/Updates

6.6 Salius Pharma

6.6.1 Salius Pharma Company Information

6.6.2 Salius Pharma Description and Business Overview

6.6.3 Salius Pharma Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Salius Pharma Anti-helminthic Drugs Product Portfolio

6.6.5 Salius Pharma Recent Developments/Updates

6.7 Johnson & Johnson

6.7.1 Johnson & Johnson Company Information

6.7.2 Johnson & Johnson Description and Business Overview

6.7.3 Johnson & Johnson Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Johnson & Johnson Anti-helminthic Drugs Product Portfolio

6.7.5 Johnson & Johnson Recent Developments/Updates

6.8 Amneal Pharmaceuticals

6.8.1 Amneal Pharmaceuticals Company Information

6.8.2 Amneal Pharmaceuticals Description and Business Overview

6.8.3 Amneal Pharmaceuticals Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Amneal Pharmaceuticals Anti-helminthic Drugs Product Portfolio

6.8.5 Amneal Pharmaceuticals Recent Developments/Updates

6.9 Cadila Pharmaceuticals

6.9.1 Cadila Pharmaceuticals Company Information

6.9.2 Cadila Pharmaceuticals Description and Business Overview

6.9.3 Cadila Pharmaceuticals Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Cadila Pharmaceuticals Anti-helminthic Drugs Product Portfolio

6.9.5 Cadila Pharmaceuticals Recent Developments/Updates

6.10 Eipico

6.10.1 Eipico Company Information

6.10.2 Eipico Description and Business Overview

6.10.3 Eipico Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Eipico Anti-helminthic Drugs Product Portfolio

6.10.5 Eipico Recent Developments/Updates

6.11 Esteve Pharmaceuticals

6.11.1 Esteve Pharmaceuticals Company Information

6.11.2 Esteve Pharmaceuticals Description and Business Overview

6.11.3 Esteve Pharmaceuticals Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Esteve Pharmaceuticals Anti-helminthic Drugs Product Portfolio

6.11.5 Esteve Pharmaceuticals Recent Developments/Updates

6.12 Merck

6.12.1 Merck Company Information

6.12.2 Merck Description and Business Overview

6.12.3 Merck Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Merck Anti-helminthic Drugs Product Portfolio

6.12.5 Merck Recent Developments/Updates

6.13 Shanghai Tengrui Pharmaceutical Co., Ltd.

6.13.1 Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information

6.13.2 Shanghai Tengrui Pharmaceutical Co., Ltd. Description and Business Overview

6.13.3 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.13.5 Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments/Updates

6.14 Shaanxi Hanwang Pharmaceutical Co., Ltd.

6.14.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information

6.14.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Description and Business Overview

6.14.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.14.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.15 Beijing Taiyang Pharmaceutical Co., Ltd.

6.15.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information

6.15.2 Beijing Taiyang Pharmaceutical Co., Ltd. Description and Business Overview

6.15.3 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.15.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.16 Guilin Nanyao Pharmaceutical Co., Ltd.

6.16.1 Guilin Nanyao Pharmaceutical Co., Ltd. Company Information

6.16.2 Guilin Nanyao Pharmaceutical Co., Ltd. Description and Business Overview

6.16.3 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.16.5 Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments/Updates

6.17 Fujian Dongrui Pharmaceutical Co., Ltd.

6.17.1 Fujian Dongrui Pharmaceutical Co., Ltd. Company Information

6.17.2 Fujian Dongrui Pharmaceutical Co., Ltd. Description and Business Overview

6.17.3 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.17.5 Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments/Updates

6.18 Jiaozuo Furuitang Pharmaceutical Co., Ltd.

6.18.1 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information

6.18.2 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Description and Business Overview

6.18.3 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.18.5 Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.19 Shaoxing Minsheng Pharmaceutical Co., Ltd.

6.19.1 Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information

6.19.2 Shaoxing Minsheng Pharmaceutical Co., Ltd. Description and Business Overview

6.19.3 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.19.4 Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.19.5 Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments/Updates

6.20 Chengdu Hengda Pharmaceutical Co., Ltd.

6.20.1 Chengdu Hengda Pharmaceutical Co., Ltd. Company Information

6.20.2 Chengdu Hengda Pharmaceutical Co., Ltd. Description and Business Overview

6.20.3 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.20.4 Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.20.5 Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments/Updates

6.21 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

6.21.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information

6.21.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Description and Business Overview

6.21.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.21.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.21.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments/Updates

6.22 Diao Group Chengdu Pharmaceutical Co., Ltd.

6.22.1 Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information

6.22.2 Diao Group Chengdu Pharmaceutical Co., Ltd. Description and Business Overview

6.22.3 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.22.4 Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.22.5 Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments/Updates

6.23 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

6.23.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information

6.23.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Description and Business Overview

6.23.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.23.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.23.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments/Updates

6.24 Anhui Shengying Pharmaceutical Co., Ltd.

6.24.1 Anhui Shengying Pharmaceutical Co., Ltd. Company Information

6.24.2 Anhui Shengying Pharmaceutical Co., Ltd. Description and Business Overview

6.24.3 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.24.4 Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.24.5 Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments/Updates

6.25 Sichuan Tiande Pharmaceutical Co., Ltd.

6.25.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information

6.25.2 Sichuan Tiande Pharmaceutical Co., Ltd. Description and Business Overview

6.25.3 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.25.4 Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.25.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments/Updates

6.26 Hubei Ruihua Pharmaceutical Co., Ltd.

6.26.1 Hubei Ruihua Pharmaceutical Co., Ltd. Company Information

6.26.2 Hubei Ruihua Pharmaceutical Co., Ltd. Description and Business Overview

6.26.3 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.26.4 Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.26.5 Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments/Updates

6.27 Zhejiang Anbet Pharmaceutical Co., Ltd.

6.27.1 Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information

6.27.2 Zhejiang Anbet Pharmaceutical Co., Ltd. Description and Business Overview

6.27.3 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.27.4 Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.27.5 Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments/Updates

6.28 Nanjing Pharmaceutical Factory Co., Ltd.

6.28.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information

6.28.2 Nanjing Pharmaceutical Factory Co., Ltd. Description and Business Overview

6.28.3 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.28.4 Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.28.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates

6.29 Zhejiang Hisun Pharmaceutical Co., Ltd.

6.29.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information

6.29.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview

6.29.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.29.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.29.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates

6.30 Southwest Pharmaceutical Co., Ltd.

6.30.1 Southwest Pharmaceutical Co., Ltd. Company Information

6.30.2 Southwest Pharmaceutical Co., Ltd. Description and Business Overview

6.30.3 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales, Revenue and Gross Margin (2019-2024)

6.30.4 Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product Portfolio

6.30.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Anti-helminthic Drugs Industry Chain Analysis

7.2 Anti-helminthic Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Anti-helminthic Drugs Production Mode & Process

7.4 Anti-helminthic Drugs Sales and Marketing

7.4.1 Anti-helminthic Drugs Sales Channels

7.4.2 Anti-helminthic Drugs Distributors

7.5 Anti-helminthic Drugs Customers

8 Anti-helminthic Drugs Market Dynamics

8.1 Anti-helminthic Drugs Industry Trends

8.2 Anti-helminthic Drugs Market Drivers

8.3 Anti-helminthic Drugs Market Challenges

8.4 Anti-helminthic Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GlaxoSmithKline PLC

Sequent Scientific

K.A.Malle Pharmaceuticals

Lasa Supergenerics Limited

Fredun Pharmaceuticals Ltd

Salius Pharma

Johnson & Johnson

Amneal Pharmaceuticals

Cadila Pharmaceuticals

EIPICO

Esteve Pharmaceuticals

Merck

Shanghai Tengrui Pharmaceutical Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Guilin Nanyao Pharmaceutical Co., Ltd.

Fujian Dongrui Pharmaceutical Co., Ltd.

Jiaozuo Furuitang Pharmaceutical Co., Ltd.

Shaoxing Minsheng Pharmaceutical Co., Ltd

Chengdu Hengda Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Diao Group Chengdu Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Anhui Shengying Pharmaceutical Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Hubei Ruihua Pharmaceutical Co., Ltd.

Zhejiang Anbet Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical Factory Co;ltd

Zhejiang Hisun Pharmaceutical Co Ltd

Southwest Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Anti-helminthic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Anti-helminthic Drugs Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Anti-helminthic Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Anti-helminthic Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Anti-helminthic Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Anti-helminthic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Anti-helminthic Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Anti-helminthic Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Anti-helminthic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Anti-helminthic Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Anti-helminthic Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Anti-helminthic Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Anti-helminthic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-helminthic Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-helminthic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Anti-helminthic Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Anti-helminthic Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Anti-helminthic Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Anti-helminthic Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Anti-helminthic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Anti-helminthic Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Anti-helminthic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Anti-helminthic Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Anti-helminthic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Anti-helminthic Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Anti-helminthic Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Anti-helminthic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Anti-helminthic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Anti-helminthic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Anti-helminthic Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Anti-helminthic Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Anti-helminthic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Anti-helminthic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Anti-helminthic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Anti-helminthic Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Anti-helminthic Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Anti-helminthic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Anti-helminthic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Anti-helminthic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Anti-helminthic Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Anti-helminthic Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Anti-helminthic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Anti-helminthic Drugs Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Anti-helminthic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Anti-helminthic Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Anti-helminthic Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Anti-helminthic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Anti-helminthic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Anti-helminthic Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Anti-helminthic Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Anti-helminthic Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Anti-helminthic Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Anti-helminthic Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Anti-helminthic Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Anti-helminthic Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Anti-helminthic Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Anti-helminthic Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Anti-helminthic Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Anti-helminthic Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Anti-helminthic Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Anti-helminthic Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Anti-helminthic Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Anti-helminthic Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Anti-helminthic Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Anti-helminthic Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Anti-helminthic Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Anti-helminthic Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Anti-helminthic Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. GlaxoSmithKline Company Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. GlaxoSmithKline Anti-helminthic Drugs Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Sequent Scientific Company Information

Table 76. Sequent Scientific Description and Business Overview

Table 77. Sequent Scientific Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Sequent Scientific Anti-helminthic Drugs Product

Table 79. Sequent Scientific Recent Developments/Updates

Table 80. K.A. Malle Pharmaceuticals Company Information

Table 81. K.A. Malle Pharmaceuticals Description and Business Overview

Table 82. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product

Table 84. K.A. Malle Pharmaceuticals Recent Developments/Updates

Table 85. Lasa Supergenerics Limited Company Information

Table 86. Lasa Supergenerics Limited Description and Business Overview

Table 87. Lasa Supergenerics Limited Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Lasa Supergenerics Limited Anti-helminthic Drugs Product

Table 89. Lasa Supergenerics Limited Recent Developments/Updates

Table 90. Fredun Pharmaceuticals Ltd Company Information

Table 91. Fredun Pharmaceuticals Ltd Description and Business Overview

Table 92. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product

Table 94. Fredun Pharmaceuticals Ltd Recent Developments/Updates

Table 95. Salius Pharma Company Information

Table 96. Salius Pharma Description and Business Overview

Table 97. Salius Pharma Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Salius Pharma Anti-helminthic Drugs Product

Table 99. Salius Pharma Recent Developments/Updates

Table 100. Johnson & Johnson Company Information

Table 101. Johnson & Johnson Description and Business Overview

Table 102. Johnson & Johnson Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Johnson & Johnson Anti-helminthic Drugs Product

Table 104. Johnson & Johnson Recent Developments/Updates

Table 105. Amneal Pharmaceuticals Company Information

Table 106. Amneal Pharmaceuticals Description and Business Overview

Table 107. Amneal Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Amneal Pharmaceuticals Anti-helminthic Drugs Product

Table 109. Amneal Pharmaceuticals Recent Developments/Updates

Table 110. Cadila Pharmaceuticals Company Information

Table 111. Cadila Pharmaceuticals Description and Business Overview

Table 112. Cadila Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Cadila Pharmaceuticals Anti-helminthic Drugs Product

Table 114. Cadila Pharmaceuticals Recent Developments/Updates

Table 115. Eipico Company Information

Table 116. Eipico Description and Business Overview

Table 117. Eipico Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Eipico Anti-helminthic Drugs Product

Table 119. Eipico Recent Developments/Updates

Table 120. Esteve Pharmaceuticals Company Information

Table 121. Esteve Pharmaceuticals Description and Business Overview

Table 122. Esteve Pharmaceuticals Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Esteve Pharmaceuticals Anti-helminthic Drugs Product

Table 124. Esteve Pharmaceuticals Recent Developments/Updates

Table 125. Merck Company Information

Table 126. Merck Description and Business Overview

Table 127. Merck Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Merck Anti-helminthic Drugs Product

Table 129. Merck Recent Developments/Updates

Table 130. Shanghai Tengrui Pharmaceutical Co., Ltd. Company Information

Table 131. Shanghai Tengrui Pharmaceutical Co., Ltd. Description and Business Overview

Table 132. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Shanghai Tengrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 134. Shanghai Tengrui Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 135. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information

Table 136. Shaanxi Hanwang Pharmaceutical Co., Ltd. Description and Business Overview

Table 137. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Shaanxi Hanwang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 139. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 140. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information

Table 141. Beijing Taiyang Pharmaceutical Co., Ltd. Description and Business Overview

Table 142. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Beijing Taiyang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 144. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 145. Guilin Nanyao Pharmaceutical Co., Ltd. Company Information

Table 146. Guilin Nanyao Pharmaceutical Co., Ltd. Description and Business Overview

Table 147. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Guilin Nanyao Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 149. Guilin Nanyao Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 150. Fujian Dongrui Pharmaceutical Co., Ltd. Company Information

Table 151. Fujian Dongrui Pharmaceutical Co., Ltd. Description and Business Overview

Table 152. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Fujian Dongrui Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 154. Fujian Dongrui Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 155. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Company Information

Table 156. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Description and Business Overview

Table 157. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 159. Jiaozuo Furuitang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 160. Shaoxing Minsheng Pharmaceutical Co., Ltd. Company Information

Table 161. Shaoxing Minsheng Pharmaceutical Co., Ltd. Description and Business Overview

Table 162. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 163. Shaoxing Minsheng Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 164. Shaoxing Minsheng Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 165. Chengdu Hengda Pharmaceutical Co., Ltd. Company Information

Table 166. Chengdu Hengda Pharmaceutical Co., Ltd. Description and Business Overview

Table 167. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 168. Chengdu Hengda Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 169. Chengdu Hengda Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 170. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information

Table 171. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Description and Business Overview

Table 172. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 173. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 174. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 175. Diao Group Chengdu Pharmaceutical Co., Ltd. Company Information

Table 176. Diao Group Chengdu Pharmaceutical Co., Ltd. Description and Business Overview

Table 177. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 178. Diao Group Chengdu Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 179. Diao Group Chengdu Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 180. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information

Table 181. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Description and Business Overview

Table 182. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 183. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 184. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 185. Anhui Shengying Pharmaceutical Co., Ltd. Company Information

Table 186. Anhui Shengying Pharmaceutical Co., Ltd. Description and Business Overview

Table 187. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 188. Anhui Shengying Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 189. Anhui Shengying Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 190. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information

Table 191. Sichuan Tiande Pharmaceutical Co., Ltd. Description and Business Overview

Table 192. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 193. Sichuan Tiande Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 194. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 195. Hubei Ruihua Pharmaceutical Co., Ltd. Company Information

Table 196. Hubei Ruihua Pharmaceutical Co., Ltd. Description and Business Overview

Table 197. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 198. Hubei Ruihua Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 199. Hubei Ruihua Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 200. Zhejiang Anbet Pharmaceutical Co., Ltd. Company Information

Table 201. Zhejiang Anbet Pharmaceutical Co., Ltd. Description and Business Overview

Table 202. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 203. Zhejiang Anbet Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 204. Zhejiang Anbet Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 205. Nanjing Pharmaceutical Factory Co., Ltd. Company Information

Table 206. Nanjing Pharmaceutical Factory Co., Ltd. Description and Business Overview

Table 207. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 208. Nanjing Pharmaceutical Factory Co., Ltd. Anti-helminthic Drugs Product

Table 209. Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments/Updates

Table 210. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information

Table 211. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Business Overview

Table 212. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 213. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 214. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 215. Southwest Pharmaceutical Co., Ltd. Company Information

Table 216. Southwest Pharmaceutical Co., Ltd. Description and Business Overview

Table 217. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 218. Southwest Pharmaceutical Co., Ltd. Anti-helminthic Drugs Product

Table 219. Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 220. Key Raw Materials Lists

Table 221. Raw Materials Key Suppliers Lists

Table 222. Anti-helminthic Drugs Distributors List

Table 223. Anti-helminthic Drugs Customers List

Table 224. Anti-helminthic Drugs Market Trends

Table 225. Anti-helminthic Drugs Market Drivers

Table 226. Anti-helminthic Drugs Market Challenges

Table 227. Anti-helminthic Drugs Market Restraints

Table 228. Research Programs/Design for This Report

Table 229. Key Data Information from Secondary Sources

Table 230. Key Data Information from Primary Sources

Table 231. Authors List of This Report

List of Figures

Figure 1. Product Picture of Anti-helminthic Drugs

Figure 2. Global Anti-helminthic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Anti-helminthic Drugs Market Share by Type: 2023 & 2030

Figure 4. Praziquantel Product Picture

Figure 5. Albendazole Product Picture

Figure 6. Mimbendazole Product Picture

Figure 7. Piperazine Product Picture

Figure 8. Pyrantel Pamoate Product Picture

Figure 9. Global Anti-helminthic Drugs Market Value by Application (2024-2030) & (US$ Million)

Figure 10. Global Anti-helminthic Drugs Market Share by Application: 2023 & 2030

Figure 11. For Veterinary Use

Figure 12. For Human Use

Figure 13. Global Anti-helminthic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Anti-helminthic Drugs Market Size (2019-2030) & (US$ Million)

Figure 15. Global Anti-helminthic Drugs Sales (2019-2030) & (K Units)

Figure 16. Global Anti-helminthic Drugs Average Price (US$/Unit) & (2019-2030)

Figure 17. Anti-helminthic Drugs Report Years Considered

Figure 18. Anti-helminthic Drugs Sales Share by Manufacturers in 2023

Figure 19. Global Anti-helminthic Drugs Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest Anti-helminthic Drugs Players: Market Share by Revenue in Anti-helminthic Drugs in 2023

Figure 21. Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global Anti-helminthic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Anti-helminthic Drugs Sales Market Share by Country (2019-2030)

Figure 24. North America Anti-helminthic Drugs Revenue Market Share by Country (2019-2030)

Figure 25. United States Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Anti-helminthic Drugs Sales Market Share by Country (2019-2030)

Figure 28. Europe Anti-helminthic Drugs Revenue Market Share by Country (2019-2030)

Figure 29. Germany Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Anti-helminthic Drugs Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Anti-helminthic Drugs Revenue Market Share by Region (2019-2030)

Figure 36. China Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Anti-helminthic Drugs Sales Market Share by Country (2019-2030)

Figure 44. Mexico Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa Anti-helminthic Drugs Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa Anti-helminthic Drugs Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Anti-helminthic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Anti-helminthic Drugs by Type (2019-2030)

Figure 54. Global Revenue Market Share of Anti-helminthic Drugs by Type (2019-2030)

Figure 55. Global Anti-helminthic Drugs Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Anti-helminthic Drugs by Application (2019-2030)

Figure 57. Global Revenue Market Share of Anti-helminthic Drugs by Application (2019-2030)

Figure 58. Global Anti-helminthic Drugs Price (US$/Unit) by Application (2019-2030)

Figure 59. Anti-helminthic Drugs Value Chain

Figure 60. Anti-helminthic Drugs Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-22B7779

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Hepatitis Test Solution/Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-36Y2605

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Pediatric Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Brucella Melitensis Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-27A12787

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Anti-helminthic Drugs Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-21S18128

Global Anti-helminthic Drugs Market Research Report 2024

FEATURED COMPANIES

Anti-helminthic Drugs Market

Report Scope

Scope of Anti-helminthic Drugs Market Report

Core Chapters

FAQ for this report

Who are the main players in the Anti-helminthic Drugs Market report?

What are the Application segmentation covered in the Anti-helminthic Drugs Market report?

What are the Type segmentation covered in the Anti-helminthic Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS